Últimas noticias sobre BeyondSpring (NASDAQ:BYSI) Bolsa

BeyondSpring

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.

BeyondSpring Inc

<p>HC Wainwright &amp; Co.  analyst Joseph Pantginis   reiterates Compass Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPX#NASDAQ">CMPX</a>) with a Buy and maintains $10 price target.</p>


News

Price Target

Reiteration

Analyst Ratings

CMPX

HC Wainwright & Co. Reiterates Buy on Compass Therapeutics, Maintains $10 Price Target

<p>HC Wainwright &amp; Co.  analyst Ed Arce   reiterates Sagimet Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMT#NASDAQ">SGMT</a>) with a Buy and maintains $32 price target.</p>


SGMT

HC Wainwright & Co. Reiterates Buy on Sagimet Biosciences, Maintains $32 Price Target

<p>HC Wainwright &amp; Co.  analyst Yi Chen   reiterates Kala Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALA#NASDAQ">KALA</a>) with a Buy and maintains $15 price target.</p>


KALA

HC Wainwright & Co. Reiterates Buy on Kala Bio, Maintains $15 Price Target

<p>Keurig Dr Pepper (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>) has outperformed the market over the past 15 years by 2.32% on an annualized basis producing an average annual return of 14.04%. Currently, Keurig Dr Pepper has a market capitalization of $45.06 billion. </p>
<p><strong>Buying $1000 In KDP:</strong> If an investor had bought $1000 of KDP stock 15 years ago, it would be worth <strong>$7,196.06</strong> today based on a price of $33.22 for KDP at the time of writing.</p>
<h3>Keurig Dr Pepper's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731699205_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Trading Ideas

$1000 Invested In Keurig Dr Pepper 15 Years Ago Would Be Worth This Much Today

<p>HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) has outperformed the market over the past 10 years by 6.46% on an annualized basis producing an average annual return of 17.48%. Currently, HCA Healthcare has a market capitalization of $87.70 billion. </p>
<p><strong>Buying $100 In HCA:</strong> If an investor had bought $100 of HCA stock 10 years ago, it would be worth <strong>$506.91</strong> today based on a price of $339.83 for HCA at the time of writing.</p>
<h3>HCA Healthcare's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731699201_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today

<p>Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) has outperformed the market over the past 10 years by 18.87% on an annualized basis producing an average annual return of 29.89%. Currently, Fabrinet has a market capitalization of $9.04 billion. </p>
<p><strong>Buying $1000 In FN:</strong> If an investor had bought $1000 of FN stock 10 years ago, it would be worth <strong>$13,993.98</strong> today based on a price of $249.31 for FN at the time of writing.</p>
<h3>Fabrinet's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731699196_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Here's How Much You Would Have Made Owning Fabrinet Stock In The Last 10 Years

<p>First Citizens BancShares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>) has outperformed the market over the past 20 years by 6.83% on an annualized basis producing an average annual return of 15.15%. Currently, First Citizens BancShares has a market capitalization of $30.11 billion. </p>
<p><strong>Buying $100 In FCNCA:</strong> If an investor had bought $100 of FCNCA stock 20 years ago, it would be worth <strong>$1,728.18</strong> today based on a price of $2152.02 for FCNCA at the time of writing.</p>
<h3>First Citizens BancShares's Performance Over Last 20 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731699191_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


FCNCA

If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,700 Today

<p>HC Wainwright &amp; Co.  analyst Edward White   reiterates 60 Degrees (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>) with a Neutral.</p>


SXTP

HC Wainwright & Co. Reiterates Neutral on 60 Degrees

<p>Johnson Controls Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) has outperformed the market over the past 15 years by 1.85% on an annualized basis producing an average annual return of 13.57%. Currently, Johnson Controls Intl has a market capitalization of $56.41 billion. </p>
<p><strong>Buying $100 In JCI:</strong> If an investor had bought $100 of JCI stock 15 years ago, it would be worth <strong>$684.45</strong> today based on a price of $84.45 for JCI at the time of writing.</p>
<h3>Johnson Controls Intl's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731699187_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$100 Invested In Johnson Controls Intl 15 Years Ago Would Be Worth This Much Today

<p>Crown Castle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCI#NYSE">CCI</a>) has outperformed the market over the past 20 years by 1.26% on an annualized basis producing an average annual return of 9.59%. Currently, Crown Castle has a market capitalization of $44.95 billion. </p>
<p><strong>Buying $1000 In CCI:</strong> If an investor had bought $1000 of CCI stock 20 years ago, it would be worth <strong>$6,268.48</strong> today based on a price of $103.43 for CCI at the time of writing.</p>
<h3>Crown Castle's Performance Over Last 20 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731699182_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Here's How Much You Would Have Made Owning Crown Castle Stock In The Last 20 Years

<p>Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) has outperformed the market over the past 20 years by 2.84% on an annualized basis producing an average annual return of 11.16%. Currently, Texas Instruments has a market capitalization of $184.14 billion. </p>
<p><strong>Buying $100 In TXN:</strong> If an investor had bought $100 of TXN stock 20 years ago, it would be worth <strong>$822.22</strong> today based on a price of $201.85 for TXN at the time of writing.</p>
<h3>Texas Instruments's Performance Over Last 20 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731699176_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$100 Invested In Texas Instruments 20 Years Ago Would Be Worth This Much Today

<p>Comfort Systems USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIX#NYSE">FIX</a>) has outperformed the market over the past 15 years by 15.86% on an annualized basis producing an average annual return of 27.59%. Currently, Comfort Systems USA has a market capitalization of $15.82 billion. </p>
<p><strong>Buying $1000 In FIX:</strong> If an investor had bought $1000 of FIX stock 15 years ago, it would be worth <strong>$40,251.81</strong> today based on a price of $444.38 for FIX at the time of writing.</p>
<h3>Comfort Systems USA's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731699171_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Here's How Much $1000 Invested In Comfort Systems USA 15 Years Ago Would Be Worth Today

<p>CRH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRH#NYSE">CRH</a>) has outperformed the market over the past 5 years by 8.02% on an annualized basis producing an average annual return of 21.4%. Currently, CRH has a market capitalization of $66.88 billion. </p>
<p><strong>Buying $1000 In CRH:</strong> If an investor had bought $1000 of CRH stock 5 years ago, it would be worth <strong>$2,673.92</strong> today based on a price of $98.52 for CRH at the time of writing.</p>
<h3>CRH's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731699167_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,700 Today

<p>W.W. Grainger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWW#NYSE">GWW</a>) has outperformed the market over the past 15 years by 6.27% on an annualized basis producing an average annual return of 17.99%. Currently, W.W. Grainger has a market capitalization of $57.42 billion. </p>
<p><strong>Buying $100 In GWW:</strong> If an investor had bought $100 of GWW stock 15 years ago, it would be worth <strong>$1,209.17</strong> today based on a price of $1176.01 for GWW at the time of writing.</p>
<h3>W.W. Grainger's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731699162_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,200 Today

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>KLA</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with KLAC, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 19 uncommon options trades for KLA.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 52% bullish and 36%, bearish.</p>
<p>Out of all of the special options we uncovered, 13 are puts, for a total amount of $635,864, and 6 are calls, for a total amount of $411,004.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $500.0 to $770.0 for KLA over the last 3 months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for KLA's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across KLA's significant trades, within a strike price range of $500.0 to $770.0, over the past month.</p>
<h3>KLA Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731699125_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>KLAC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$66.0</td>
<td>$64.9</td>
<td>$66.0</td>
<td>$650.00</td>
<td>$237.6K</td>
<td align="right">4</td>
<td align="right">36</td>
</tr>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$49.0</td>
<td>$44.0</td>
<td>$44.0</td>
<td>$670.00</td>
<td>$88.0K</td>
<td align="right">264</td>
<td align="right">21</td>
</tr>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$30.2</td>
<td>$27.5</td>
<td>$28.8</td>
<td>$630.00</td>
<td>$83.2K</td>
<td align="right">117</td>
<td align="right">60</td>
</tr>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$17.7</td>
<td>$15.1</td>
<td>$17.8</td>
<td>$640.00</td>
<td>$70.8K</td>
<td align="right">984</td>
<td align="right">157</td>
</tr>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$31.6</td>
<td>$27.8</td>
<td>$29.7</td>
<td>$630.00</td>
<td>$62.3K</td>
<td align="right">117</td>
<td align="right">28</td>
</tr>
</tbody>
</table>
</p>
<h3>About KLA</h3>
<p>KLA is one of the largest semiconductor wafer fabrication equipment, or WFE, manufacturers in the world. It specializes in the market segment of semiconductor process control, wherein machines inspect semiconductor wafers during research and development and manufacturing for defects and verify precise measurements. In this section of the market, KLA holds a majority share. It also has a small exposure to the etch and deposition segments of the WFE market. It counts as top customers the largest chipmakers in the world, including TSMC and Samsung.</p>
<p>Following our analysis of the options activities associated with KLA, we pivot to a closer look at the company's own performance.</p>
<h3>KLA's Current Market Status</h3>
<ul>
<li>With a volume of 823,831, the price of KLAC is down -4.03% at $619.0. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 69 days.</li>
</ul>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for KLA with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

Markets

KLAC

A Closer Look at KLA's Options Market Dynamics

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Alcoa</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AA, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 11 options trades for <strong>Alcoa</strong>.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 72% bullish and 18%, bearish.</p>
<p>Out of all of the options we uncovered, there was 1 put, for a total amount of $27,590, and 10, calls, for a total amount of $360,648.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $30.0 to $50.0 for Alcoa over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In today's trading context, the average open interest for options of Alcoa stands at 4479.5, with a total volume reaching 29,752.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Alcoa, situated within the strike price corridor from $30.0 to $50.0, throughout the last 30 days.</p>
<h3>Alcoa Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731699120_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$17.75</td>
<td>$17.65</td>
<td>$17.75</td>
<td>$30.00</td>
<td>$65.6K</td>
<td>1.1K</td>
<td>0</td>
</tr>
<tr>
<td>AA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.84</td>
<td>$1.77</td>
<td>$1.82</td>
<td>$50.00</td>
<td>$58.2K</td>
<td>14.7K</td>
<td>352</td>
</tr>
<tr>
<td>AA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$5.8</td>
<td>$5.75</td>
<td>$5.8</td>
<td>$40.00</td>
<td>$36.5K</td>
<td>3.9K</td>
<td>1.5K</td>
</tr>
<tr>
<td>AA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$0.5</td>
<td>$0.49</td>
<td>$0.5</td>
<td>$44.50</td>
<td>$34.4K</td>
<td>580</td>
<td>9.0K</td>
</tr>
<tr>
<td>AA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$6.15</td>
<td>$6.05</td>
<td>$6.1</td>
<td>$40.00</td>
<td>$31.1K</td>
<td>3.9K</td>
<td>1.4K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Alcoa</h3>
<p>Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is the world's largest bauxite miner and alumina refiner by production volume, and the eighth-largest aluminum producer. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024, meaning refining assets are now predominantly wholly owned, as with smelting.</p>
<h3>Alcoa's Current Market Status</h3>
<ul>
<li>With a trading volume of 8,829,143, the price of AA is up by 7.13%, reaching $44.15.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 61 days from now.</li>
</ul>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Alcoa with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Alcoa Unusual Options Activity For November 15

<p>Deep-pocketed investors have adopted a bullish approach towards Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in WDAY usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Workday. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 2 are puts, totaling $307,567, and 6 are calls, amounting to $303,662.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $200.0 and $300.0 for Workday, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Workday's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Workday's whale activity within a strike price range from $200.0 to $300.0 in the last 30 days. </p>
<h3>Workday Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731699115_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>WDAY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$14.5</td>
<td>$14.4</td>
<td>$14.5</td>
<td>$260.00</td>
<td>$259.5K</td>
<td>302</td>
<td align="right">182</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$101.2</td>
<td>$97.0</td>
<td>$99.7</td>
<td>$200.00</td>
<td>$99.7K</td>
<td>7</td>
<td align="right">15</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$18.5</td>
<td>$18.2</td>
<td>$18.2</td>
<td>$260.00</td>
<td>$63.7K</td>
<td>2.0K</td>
<td align="right">58</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$101.6</td>
<td>$100.0</td>
<td>$100.0</td>
<td>$200.00</td>
<td>$50.0K</td>
<td>7</td>
<td align="right">0</td>
</tr>
<tr>
<td>WDAY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$40.9</td>
<td>$40.0</td>
<td>$40.0</td>
<td>$280.00</td>
<td>$48.0K</td>
<td>2</td>
<td align="right">12</td>
</tr>
</tbody>
</table>
</p>
<h3>About Workday</h3>
<p>Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 18,000 employees.</p>
<h3>Where Is Workday Standing Right Now?</h3>
<ul>
<li>With a volume of 1,151,193, the price of WDAY is down -4.12% at $260.31. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 11 days.</li>
</ul>
<h3>Professional Analyst Ratings for Workday</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $270.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Loop Capital keeps a Hold rating on Workday with a target price of $270. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Workday with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


WDAY

Looking At Workday's Recent Unusual Options Activity

<p>HC Wainwright &amp; Co.  analyst Patrick Trucchio   reiterates Silence Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLN#NASDAQ">SLN</a>) with a Buy and maintains $75 price target.</p>


HC Wainwright & Co. Reiterates Buy on Silence Therapeutics, Maintains $75 Price Target

<p>HC Wainwright &amp; Co.  analyst Swayampakula Ramakanth   reiterates Celcuity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELC#NASDAQ">CELC</a>) with a Buy and maintains $27 price target.</p>


CELC

HC Wainwright & Co. Reiterates Buy on Celcuity, Maintains $27 Price Target

<p>HC Wainwright &amp; Co.  analyst Edward White   reiterates Curis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRIS#NASDAQ">CRIS</a>) with a Buy and maintains $20 price target.</p>


CRIS

HC Wainwright & Co. Reiterates Buy on Curis, Maintains $20 Price Target

BeyondSpring, enVVeno Medical, Aptorum Group among healthcare movers

Beyondspring Inc (BYSI) is around the top of the Biotechnology industry according to InvestorsObserver. BYSI received an overall rating of 67, which means that it scores higher than 67 percent of all stocks. Beyondspring Inc also achieved a score of 76 in the Biotechnology industry, putting it above 76 percent of Biotechno

Beyondspring Inc (BYSI) has gained 125.56% in a Week, Should You Buy?

Beyondspring (BYSI) has released an update. BeyondSpring Inc. announces the retirement of Chief Scientific Officer G. Kenneth Lloyd, effective Marc...

BeyondSpring Announces Executive Leadership Change

iBio, Mesoblast, Kodiak Sciences among healthcare movers

BeyondSpring GAAP EPS of -$1.64, revenue of $1.35M

BeyondSpring GAAP EPS of -$0.54, revenue of $1.75M

Beyondspring (BYSI) has released an update. BeyondSpring Inc., a biopharmaceutical company, has successfully filed a registration statement with th...

BeyondSpring Inc. Announces Share Issuance

BeyondSpring files to offer up to 10M ordinary shares

Beyondspring (BYSI) has released an update. BeyondSpring Inc., a foreign private issuer, has reported its financial results for the first half of 2...

BeyondSpring Inc. Reports Mid-Year Financials

BeyondSpring plinabulin, Merck Keytruda combo shows promise in NSCLC

AVTX

BIAF

BYSI

CRVO

IBIO

LIFW

MESO

NVNO

PAVM

SERA

TCBP

XRTX

ZCMD

Press Releases

BeyondSpring Files 2023 Annual Report on Form 20-F

Earnings

BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results

BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics

Health Care

BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics

SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications

BeyondSpring Announces Oral Presentation at the 2024 World Conference on Lung Cancer and Two Poster Presentations During ESMO Congress 2024 Showcasing its Lead Anti-Cancer Asset, Plinabulin

BeyondSpring Delivers Oral Presentation at ISLAC 2024 World Conference on Lung Cancer of its Lead Anti-Cancer Asset Plinabulin Showcasing Positive Final Phase 3 Data in 2L/3L NSCLC EGFR Wild-Type with Concurrent Publication in the Lancet Respiratory Medicine

General

BeyondSpring Presents Efficacy/Safety Results from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at ESMO Congress 2024

BeyondSpring Presents Final Data Analysis of DUBLIN-3 Phase 3 Study in 2L/3L EGFR Wild-type NSCLC at ESMO Congress 2024

BeyondSpring Presents Updated Efficacy Results from a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on Prior Immune Checkpoint Inhibitors at the 39th SITC Annual Meeting

Comments

BeyondSpring

Noticias

Últimas noticias sobre BeyondSpring (NASDAQ:BYSI) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL